Cerus reported $27.76M in Stock for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Cerus CERS:US $ 27.76M 0.76M
Cytori Therapeutics CYTX:US $ 0M 0M
Haemonetics HAE:US $ 277.89M 15.14M
Meridian Bioscience VIVO:US $ 70.1M 0.82M
Nuvasive NUVA:US $ 331.71M 7.3M
Orasure Technologies OSUR:US $ 71.3M 9.77M
Quidel QDEL:US $ 552.7M 371.31M
Rockwell Medical RMTI:US $ 5.17M 0.36M
Staar Surgical STAA:US $ 18.09M 0.36M